Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALNY - Alnylam Pharmaceuticals EPS misses by $0.05 beats on revenue; Revenue outlook raised

ALNY - Alnylam Pharmaceuticals EPS misses by $0.05 beats on revenue; Revenue outlook raised

Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals (NASDAQ:ALNY): Q2 Non-GAAP EPS of -$1.30 misses by $0.05; GAAP EPS of -$1.61 beats by $0.02. Revenue of $220.55M (+112.1% Y/Y) beats by $26.89M. FY21 Guidance: Combined net product revenues for ONPATTRO, GIVLAARI and OXLUMO: $640M - $665M from previous outlook of $610M - $660M. Press Release

For further details see:

Alnylam Pharmaceuticals EPS misses by $0.05, beats on revenue; Revenue outlook raised
Stock Information
Company Name: Alnylam Pharmaceuticals Inc.
Stock Symbol: ALNY
Market: NASDAQ
Website: alnylam.com
Menu
ALNY ALNY Quote ALNY Short ALNY News ALNY Articles ALNY Message Board
Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...